Details for New Drug Application (NDA): 209752
✉ Email this page to a colleague
The generic ingredient in OLOPATADINE HYDROCHLORIDE is olopatadine hydrochloride. There are seventeen drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the olopatadine hydrochloride profile page.
Summary for 209752
Tradename: | OLOPATADINE HYDROCHLORIDE |
Applicant: | Gland Pharma Ltd |
Ingredient: | olopatadine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 209752
Mechanism of Action | Histamine H1 Receptor Antagonists |
Physiological Effect | Decreased Histamine Release |
Medical Subject Heading (MeSH) Categories for 209752
Suppliers and Packaging for NDA: 209752
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
OLOPATADINE HYDROCHLORIDE | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 209752 | ANDA | Walgreens Company | 0363-7131 | 0363-7131-25 | 1 BOTTLE, PLASTIC in 1 CARTON (0363-7131-25) / 2.5 mL in 1 BOTTLE, PLASTIC |
OLOPATADINE HYDROCHLORIDE | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 209752 | ANDA | Rugby Laboratories | 0536-1307 | 0536-1307-23 | 1 BOTTLE, PLASTIC in 1 CARTON (0536-1307-23) / 2.5 mL in 1 BOTTLE, PLASTIC |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | EQ 0.2% BASE | ||||
Approval Date: | May 20, 2020 | TE: | RLD: | No |
Complete Access Available with Subscription